American Society for Clinical Pharmacology and Therapeutics (ASCPT)-111th Annual Meeting 17-20 March 2010, Atlanta, GA, USA

被引：0

作者：

Veryard, Claire ^{[1
]}

机构：

[1] Thomson Reuters, London EC1N 8JS, England

来源：

IDRUGS | 2010年 / 13卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, held in Atlanta, included topics covering disclosures of new data in the field of pharmacokinetics and drug interactions. This conference report highlights selected presentations on pharmacokinetic studies of several investigational drugs, including evatanepag (Pfizer Inc), AEG-33773 (Aegera Therapeutics Inc), JNJ-16269110 (Johnson & Johnson Pharmaceutical Research & Development LLC), PF-3716539 (ViiV Healthcare), MK-0736 (Merck & Co Inc), a combination of Ginkgo biloba and cilostazol (Renexin SK Chemicals Co Ltd), PP-101 (Pacific Pharmaceuticals Co Ltd), ACT-178882 (Acetlion Ltd/ Merck & Co Inc) and edoxaban (Daiichi Sankyo Co Ltd).

引用

页码：286 / 288

页数：3